Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-7

We are all still laughing at you for not being able to read a report. Sales $912k. The $635k is not the cost of producing the product for those sales as it includes inventory including Kava shots which are yet the hit the shelf plus, Kava bar bulk product and other production capacity costs, which will all increase sales figures over the next period. Production was ramped up massively for increased demand over the next quarters. Great problem to have.

Most of us holders know what is going on and the expected timeline to profitability, unlike yourself who jumped in got all excited pumped the crap out of it and realised it would not happen overnight.

No one can ask for anything more than the growth they are creating QoQ and YoY with more to come.

Lots of room for continued growth in all 4 pillars. Entering Kava bar market and new products will help continue growth nicely. I’m expecting a positive balance sheet by the end of this year. Who wants to predict a SP when this occurs and growth continues.